Target intelligence / Profile preview

TBL1XR1 antisense RNA 1 (TBL1XR1-AS1)

Target: TBL1XR1-AS1
Molecular classification: Other (Antisense long noncoding RNA; not a member of major drug-targetable classes like GPCRs, channels, enzymes, transporters, receptors, transcription factors, or histone modifiers.)

Overview

TBL1XR1 antisense RNA 1 (TBL1XR1-AS1) is a long noncoding RNA transcribed from the opposite strand of the TBL1XR1 locus on human chromosome 3. It is distinct from the protein-coding gene TBL1XR1, which encodes a transcriptional corepressor/coactivator implicated in cell cycle, apoptosis, and tumorigenesis[1][2][3][4][5]. There is very limited information about TBL1XR1-AS1’s function, clinical relevance, or druggability in the literature. Most research and therapeutic interest is focused on the protein TBL1XR1, not its antisense RNA transcript.

Other names: TBL1XR1 antisense RNA 1TBL1XR1-AS1

Beyond the preview

Go deeper on TBL1XR1 antisense RNA 1 (TBL1XR1-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TBL1XR1 antisense RNA 1 (TBL1XR1-AS1).

Explore the full profile